CONFERENCE SERIES: Informatics & IT
Recorded at: Bio-IT World Conference & Expo
Digital Course: Ontologies: From Drug Discovery to Clinical Data
About this Product:
Ontologies are increasingly used to formally specify objects and their relations in biological and medical domains and to drive modeling, integration, and analysis of data from genomics, proteomics, drug research, disease, treatment, and electronic health records.
This course is aimed at informatics practitioners in the biological sciences, and pharmaceutical and health care industries who are responsible for setting up and maintaining data resources covering multiple domains, and at information managers who seek to familiarize themselves with ontology driven data integration and analysis in the health care and life sciences.
About this Product:
Over 179 Minutes
Site License: $1380
Agenda At A Glance:
The course will be presented in three parts:
Introduction to basic concepts in ontology development
Overview of ontology resources
Discussion of the use of an ontology in combination with linked data in a translational medicine scenario.
No prior knowledge in ontologies or data modeling is required.
Practical examples of ontologies development and use will be presented throughout the course.
Benefits & Key Take Aways
Get a better understanding of the strengths of ontology driven data integration, management, and analysis.
Obtain practical insights on how to use ontology development tools and ontology resources.
Learn how to contribute to and benefit from open linked data projects and collaborative ontology development efforts.
Semantic web, concepts and tools – a brief overview
Basics of ontology development and the Protégé ontology editor
The Health Care and Life Sciences Ontology landscape
Use of ontology resources
Collaborative ontology development and data sharing
Case study: the Translational Medicine Ontology
Elgar Pichler, Ph.D., Computational Biologist, BostonDr. Pichler has worked as a bioinformaticist in the pharmaceutical and biotech industry for over 10 years. He is interested in the computational analysis of drug discovery processes and health care scenarios and consults on knowledge management and data modeling in these areas. He is also an active member of the W3C Health Care and Life Sciences Interest Group and contributes to open source ontology and linked open data projects.
This digital course provides special footage of all Bio-IT Keynote Sessions. The Tuesday and Wednesday Keynote presentations offered vivid examples of the current and future impact of technology in data for research and drug discovery opportunities. Also included as part of the Wednesday Keynote material is The Benjamin Franklin Award presentation. The Benjamin Franklin Award is given to an individual who has, in his or her practice, promoted free and open access to the materials and methods used in the life sciences. The Thursday Keynote panel featured a series of succinct, forward looking presentations. Special guest speakers shared their unique perspective on the future challenges facing the research, pharma, and medical communities.
Making the World’s Knowledge Computable
Stephen Wolfram, Ph.D., CEO, Wolfram Research; Creator of Wolfram\Alpha
Interacting with Complex Information Landscapes: Integration and Next Generation User Interfaces
Bryn Roberts, Ph.D., Global Head, Informatics, Pharma Research and Early Development, F. Hoffmann-La Roche
Benjamin Franklin Award & Presentation
Jonathan Eisen, Ph.D., Professor, Genome Center, University of California, Davis
Keynote Panel Chairperson
Kevin Davies, Editor-in-Chief, Bio-IT World
Pharma Futurology: 2016 and Beyond
Yury Rozenman, Global Head of Marketing, Pharmaceutical and Life Sciences Sector, BT Global Sciences
Global Risk Informatics: The Application of High Performance Computing to Public Health
Debra Goldfarb, Senior Director, Strategy, Microsoft
Ecosystem-Driven Approaches for 21st Century Biomedicine
Ken Buetow, Ph.D., Associate Director for Bioinformatics and Information Technology, National Cancer Institute
Integration of Real Time Discovery and Clinical Care
Ben Heywood, Co-founder and Chairman, PatientsLikeMe
The Goody-Gaga Effect: Health Communication at the Nexus of Social Media and Popular Culture
Mark Boguski, M.D., Ph.D., Founder, Resounding Health Incorporated
Gaming in the Workplace
Martin D. Leach, Ph.D., Executive Director, MRL IT for Discovery & Pre-Clinical Sciences, Merck & Co.
About the Conference:
Bio-IT World Conference & Expo
Enabling Technology. Leveraging Data. Transforming Medicine.
Since its debut in 2002, the annual Bio-IT World Conference & Expo (www.bio-itworldexpo.com) has established itself as a premier event showcasing the myriad applications of IT and informatics to biomedical research and the drug discovery enterprise. The Conference attracts a highly influential audience consisting of senior level scientists, IT professionals and Executives from organizations across the life sciences industry including Pharmaceutical, Biotechnology, Health Systems, Academia, Government and National Laboratories. In 2011, over 2,000 delegates gathered from 29 countries to share information and discuss enabling technologies that are driving the drug discovery process and transforming medicine. The event features concurrent tracks with 160+ technology and scientific presentations.